Patent · US Active

Intranasal compositions

US8309108B2 · kind B2 · utility

0Cited by
4References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 10, 2008
Grant dateNov 13, 2012
Priority date—
Expiry dateNov 17, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P25/16
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A liquid aqueous formulation for the intranasal administration of apomorphine includes:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.